Artiva Biotherapeutics, Inc. (ARTV) has 34 SEC Form 4 insider filings on record in the last 90 days. That includes 7 insider purchases totalling $5.4M, and 6 sales totalling $1.3M. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 | Aslan Fred Chief Executive Officer | $0 | 425,000 | +54% | No | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | Aslan Fred Chief Executive Officer | $0 | 200,000 | +41% | No | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | $0 | 16,250 | 0% | No | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | Stoppel Laura Director | $0 | 16,250 | 0% | No | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | HOUGEN ELIZABETH L Director | $0 | 16,250 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 34 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free